Literature DB >> 28858148

Alcohol or Drug Use and Trauma Recidivism.

Sergio Cordovilla-Guardia1, Raquel Vilar-López, Pablo Lardelli-Claret, Francisco Guerrero-López, Enrique Fernández-Mondéjar.   

Abstract

BACKGROUND: Alcohol, illicit drugs, and psychotropic medications are well-known causes of traumatic events. However, the association of each type of substance with trauma recidivism remains unclear.
OBJECTIVES: The purpose of this study was to quantify the strength of associations between the type of substance detected in patients admitted for traumatic injury and trauma recidivism, defined as a documented history of past trauma.
METHODS: The presence of alcohol and drugs (cannabis, cocaine, amphetamines, methamphetamines, benzodiazepines, opiates, methadone, barbiturates, and tricyclic antidepressants) was analyzed in 1,156 patients between 16 and 70 years old, hospitalized in a trauma hospital between November 2011 and March 2015. Their past trauma history was retrieved from the health information system, which included patient health histories since 1999. Multinomial logistic regression analysis was used to estimate the strength of the association between types of substances detected in current trauma patients and trauma recidivism (documented history of past trauma).
RESULTS: At least one substance was detected in 521 patients (45.1%): only alcohol in 159 (13.7%), only cannabis in 62 (5.4%), only psychotropic medications/opioids in 145 (12.5%), only cocaine/amphetamines in 14 (1.2%), and a combination of these groups in 141 (12.2%). The consumption of alcohol, illicit drugs, and/or psychotropic medications was associated with increased recidivism in all substance groups; the adjusted odds ratio for multiple recidivism was 3.17 (95% CI [2.29, 4.39]).
CONCLUSION: Patients who screened positive for alcohol, illicit drugs, and/or psychotropic medications had a higher frequency of past trauma history compared with patients with negative tests, independently of age, gender, or the presence of previous psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28858148     DOI: 10.1097/NNR.0000000000000231

Source DB:  PubMed          Journal:  Nurs Res        ISSN: 0029-6562            Impact factor:   2.381


  6 in total

1.  Opioid Use among Individuals with Traumatic Brain Injury: A Perfect Storm?

Authors:  Rachel Sayko Adams; John D Corrigan; Kristen Dams-O'Connor
Journal:  J Neurotrauma       Date:  2019-08-16       Impact factor: 5.269

2.  A System Dynamics Model of Violent Trauma and the Role of Violence Intervention Programs.

Authors:  Justin Cirone; Peter Bendix; Gary An
Journal:  J Surg Res       Date:  2019-11-06       Impact factor: 2.192

3.  Downstream hospital system effects of a comprehensive trauma recovery services program.

Authors:  Belinda DeMario; Mark J Kalina; Evelyn Truong; Sarah Hendrickson; Esther S Tseng; Jeffrey A Claridge; Heather Vallier; Vanessa P Ho
Journal:  J Trauma Acute Care Surg       Date:  2020-12       Impact factor: 3.697

4.  When should screening of pediatric trauma patients for adult behaviors start?

Authors:  Adrian A Maung; Robert D Becher; Kevin M Schuster; Kimberly A Davis
Journal:  Trauma Surg Acute Care Open       Date:  2018-04-09

5.  Association between the detection of alcohol, illicit drugs and/or psychotropic medications/opioids in patients admitted due to trauma and trauma recidivism: A cohort study.

Authors:  Sergio Cordovilla-Guardia; Celia García-Jiménez; Enrique Fernández-Mondéjar; Julián Fernando Calderón-Garcia; Fidel López-Espuela; Cristina Franco-Antonio; Sergio Rico-Martín; Pablo Lardelli-Claret
Journal:  PLoS One       Date:  2018-09-12       Impact factor: 3.240

6.  Exploring the association between initial serum alcohol concentration and polysubstance use: More than a simple "gateway drug" effect?

Authors:  Ashley Jordan; Philip Salen; Thomas R Wojda; Marissa S Cohen; Aliaskar Hasani; Joshua Luster; Jacqueline Seoane; Stanislaw P Stawicki; Holly Stankewicz
Journal:  Int J Crit Illn Inj Sci       Date:  2018 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.